Associations Between the Time in Hypoglycemia and Hypoglycemia Awareness Status in Type 1 Diabetes Patients Using Continuous Glucose Monitoring Systems

被引:17
作者
Lin, Yu Kuei [1 ]
Groat, Danielle [2 ]
Chan, Owen [1 ]
Hung, Man [3 ]
Sharma, Anu [1 ]
Varner, Michael W. [4 ]
Gouripeddi, Ramkiran [2 ]
Facelli, Julio C. [2 ]
Fisher, Simon J. [1 ]
机构
[1] Univ Utah, Sch Med, Dept Internal Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT USA
[2] Univ Utah, Dept Biomed Informat, Salt Lake City, UT USA
[3] Univ Utah, Sch Med, Study Design & Biostat Ctr, Ctr Clin & Translat Sci, Salt Lake City, UT USA
[4] Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA
关键词
Hypoglycemia; Impaired awareness of hypoglycemia; Continuous glucose monitoring; Type; 1; diabetes; IMPAIRED AWARENESS; GLYCEMIC THRESHOLDS; INSULIN INJECTIONS; AUTONOMIC FAILURE; ADULTS; COUNTERREGULATION; MULTICENTER; CONSENSUS; SYMPTOMS;
D O I
10.1089/dia.2020.0016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:Continuous glucose monitoring (CGM) systems help reduce hypoglycemia in patients with type 1 diabetes (T1D). It remains unclear whether T1D patients with impaired awareness of hypoglycemia (IAH) continue to develop more hypoglycemia than those with normal hypoglycemia awareness (NA) despite CGM use. Materials and Methods:For this cross-sectional observational study, 99 T1D patients using real-time CGMs for >= 86% of time were recruited. Fifty and 49 patients were found to have NA and IAH (based on the Clarke questionnaire), respectively. Two-week CGM hypoglycemia data were collected. Results:IAH was associated with greater percentages of CGM values <70 and <54 mg/dL (P = 0.012,P = 0.004) compared to NA. Clarke scores correlated positively with the percentage of CGM values <70 and <54 mg/dL (P = 0.013,P = 0.004). IAH was also related to more events with glucose <70 and <54 mg/dL determined either with at >= 1 time point (P = 0.048,P = 0.003) or lasting >= 20 min (P = 0.016,P = 0.004). IAH patients presented with more day-time events with glucose <54 mg/dL (P = 0.015), nocturnal events with glucose levels <70 and <54 mg/dL (P = 0.009,P = 0.007) and longer day-time event duration with glucose levels <70 and <54 mg/dL (P < 0.001,P = 0.006), respectively. Conclusions:T1D patients with IAH continue to experience more hypoglycemia despite dedicated CGM use.
引用
收藏
页码:787 / 793
页数:7
相关论文
共 40 条
  • [1] Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange
    Agiostratidou, Gina
    Anhalt, Henry
    Ball, Dana
    Blonde, Lawrence
    Gourgari, Evgenia
    Harriman, Karen N.
    Kowalski, Aaron J.
    Madden, Paul
    McAuliffe-Fogarty, Alicia H.
    McElwee-Malloy, Molly
    Peters, Anne
    Raman, Sripriya
    Reifschneider, Kent
    Rubin, Karen
    Weinzimer, Stuart A.
    [J]. DIABETES CARE, 2017, 40 (12) : 1622 - 1630
  • [2] Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitions
    Amiel, Stephanie A.
    Choudhary, Pratik
    Jacob, Peter
    Smith, Emma Lauretta
    De Zoysa, Nicole
    Gonder-Frederick, Linda
    Kendall, Mike
    Heller, Simon
    Brooks, Augustin
    Toschi, Elena
    Kariyawasam, Dulmini
    Potts, Laura
    Healy, Andy
    Rogers, Helen
    Sevdalis, Nick
    Stadler, Marietta
    Qayyum, Mustabshira
    Bakolis, Ioannis
    Goldsmith, Kimberley
    [J]. BMJ OPEN, 2019, 9 (06):
  • [3] Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
    Amiel, Stephanie A.
    Aschner, Pablo
    Childs, Belinda
    Cryer, Philip E.
    de Galan, Bastiaan E.
    Heller, Simon R.
    Frier, Brian M.
    Gonder-Frederick, Linda
    Jones, Timothy
    Khunti, Kamlesh
    Leiter, Lawrence A.
    McCrimmon, Rory J.
    Luo, Yingying
    Seaquist, Elizabeth R.
    Vigersky, Robert
    Zoungas, Sophia
    [J]. DIABETOLOGIA, 2017, 60 (01) : 3 - 6
  • [4] Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes - Reduced awakening from sleep during hypoglycemia
    Banarer, S
    Cryer, PE
    [J]. DIABETES, 2003, 52 (05) : 1195 - 1203
  • [5] Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
    Battelino, Tadej
    Danne, Thomas
    Bergenstal, Richard M.
    Amiel, Stephanie A.
    Beck, Roy
    Biester, Torben
    Bosi, Emanuele
    Buckingham, Bruce A.
    Cefalu, William T.
    Close, Kelly L.
    Cobelli, Claudio
    Dassau, Eyal
    DeVries, J. Hans
    Donaghue, Kim C.
    Dovc, Klemen
    Doyle, Francis J.
    Garg, Satish
    Grunberger, George
    Heller, Simon
    Heinemann, Lutz
    Hirsch, Irl B.
    Hovorka, Roman
    Jia, Weiping
    Kordonouri, Olga
    Kovatchev, Boris
    Kowalski, Aaron
    Laffel, Lori
    Levine, Brian
    Mayorov, Alexander
    Mathieu, Chantal
    Murphy, Helen R.
    Nimri, Revital
    Norgaard, Kirsten
    Parkin, Christopher G.
    Renard, Eric
    Rodbard, David
    Saboo, Banshi
    Schatz, Desmond
    Stoner, Keaton
    Urakami, Tatsuiko
    Weinzimer, Stuart A.
    Phillip, Moshe
    [J]. DIABETES CARE, 2019, 42 (08) : 1593 - 1603
  • [6] Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial
    Beck, Roy W.
    Riddlesworth, Tonya
    Ruedy, Katrina
    Ahmann, Andrew
    Bergenstal, Richard
    Haller, Stacie
    Kollman, Craig
    Kruger, Davida
    McGill, Janet B.
    Polonsky, William
    Toschi, Elena
    Wolpert, Howard
    Price, David
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04): : 371 - 378
  • [8] Type 1 Diabetes and Impaired Awareness of Hypoglycemia Are Associated with Reduced Brain Gray Matter Volumes
    Bednarik, Petr
    Moheet, Amir A.
    Grohn, Heidi
    Kumar, Anjali F.
    Eberly, Lynn E.
    Seaquist, Elizabeth R.
    Mangia, Silvia
    [J]. FRONTIERS IN NEUROSCIENCE, 2017, 11
  • [9] Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019
    Cefalu, William T.
    Berg, Erika Gebel
    Saraco, Mindy
    Petersen, Matthew P.
    Uelmen, Sacha
    Robinson, Shamera
    [J]. DIABETES CARE, 2019, 42 : S90 - S102
  • [10] Childs BP, 2005, DIABETES CARE, V28, P1245